ArticlePacific Symposium on Biocomputing. Pacific Symposium on Biocomputing2016
COLLECTIVE PAIRWISE CLASSIFICATION FOR MULTI-WAY ANALYSIS OF DISEASE AND DRUG DATA.
Article in Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Spatially Informed Nonnegative Matrix Trifactorization for Coclustering Mass Spectrometry Data.Biometrical journal. Biometrische Zeitschrift · 2025Article
- DRGATAN: Directed relation graph attention aware network for asymmetric drug-drug interaction prediction.iScience · 2024Article
- A Knowledge-Graph-Based Multimodal Deep Learning Framework for Identifying Drug-Drug Interactions.Molecules (Basel, Switzerland) · 2023Article
- On the robustness of generalization of drug-drug interaction models.BMC bioinformatics · 2021Article
- Survey on graph embeddings and their applications to machine learning problems on graphs.PeerJ. Computer science · 2021Article
- Machine Learning for Integrating Data in Biology and Medicine: Principles, Practice, and Opportunities.An international journal on information fusion · 2019Article
- To Embed or Not: Network Embedding as a Paradigm in Computational Biology.Frontiers in genetics · 2019Review
- Fast optimization of non-negative matrix tri-factorization.PloS one · 2019Article
- Modeling polypharmacy side effects with graph convolutional networks.Bioinformatics (Oxford, England) · 2018Article
- Large-scale analysis of disease pathways in the human interactome.Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing · 2018Article
- Positive-Unlabeled Learning for inferring drug interactions based on heterogeneous attributes.BMC bioinformatics · 2017Article
- Jumping across biomedical contexts using compressive data fusion.Bioinformatics (Oxford, England) · 2016Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Interactions between drugs, drug targets or diseases can be predicted on the basis of molecular, clinical and genomic features by, for example, exploiting similarity of disease pathways, chemical structures, activities across cell lines or clinical manifestations of diseases. A successful way to better understand complex interactions in biomedical systems is to employ collective relational learning approaches that can jointly model diverse relationships present in multiplex data. We propose a novel collective pairwise classification approach for multi-way data analysis. Our model leverages the superiority of latent factor models and classifies relationships in a large relational data domain using a pairwise ranking loss. In contrast to current approaches, our method estimates probabilities, such that probabilities for existing relationships are higher than for assumed-to-be-negative relationships. Although our method bears correspondence with the maximization of non-differentiable area under the ROC curve, we were able to design a learning algorithm that scales well on multi-relational data encoding interactions between thousands of entities.We use the new method to infer relationships from multiplex drug data and to predict connections between clinical manifestations of diseases and their underlying molecular signatures. Our method achieves promising predictive performance when compared to state-of-the-art alternative approaches and can make "category-jumping" predictions about diseases from genomic and clinical data generated far outside the molecular context.
Indexed as
Identifiers
26776175PMC4719585What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.